Bradley A Edwards,Luke D J Thomson,Daniel Vena,Andrew Gikas,Reza Radmand,Nicole Calianese,Lauren B Hess,Jinny Collet,Dillon Gilbertson,Natalie V Lawrence,Shane A Landry,Simon A Joosten,Garun S Hamilton,Andrew Wellman,Scott A Sands
{"title":"联合补充氧气和下颌推进装置治疗阻塞性睡眠呼吸暂停:一项随机对照试验。","authors":"Bradley A Edwards,Luke D J Thomson,Daniel Vena,Andrew Gikas,Reza Radmand,Nicole Calianese,Lauren B Hess,Jinny Collet,Dillon Gilbertson,Natalie V Lawrence,Shane A Landry,Simon A Joosten,Garun S Hamilton,Andrew Wellman,Scott A Sands","doi":"10.1183/13993003.01320-2025","DOIUrl":null,"url":null,"abstract":"INTRODUCTION\r\nTreatment for obstructive sleep apnoea (OSA) is limited by intolerance to continuous positive airway pressure. While OSA manifests due to both increased pharyngeal collapsibility and ventilatory control instability, randomized trials targeting both components are lacking. We tested whether combining a ventilatory control intervention (supplemental oxygen) with an upper airway mechanical intervention (mandibular advancement devices, MAD) improves treatment efficacy.\r\n\r\nMETHODS\r\nIn a multicentre randomized crossover trial, 41 patients with moderate-to-severe OSA (apnoea-hypopnoea index [AHI] >20 events/hr, scored without desaturation criteria) underwent polysomnography with four single-night interventions: oxygen (4 L·min-1), MAD, combination therapy, and sham (air). Primary analysis compared percent change in AHI from baseline between combination therapy and MAD monotherapy. Secondary outcomes included arousal index and visual analog scale for sleep quality (VASSQ). Gold-standard baseline pathophysiological traits facilitated mechanistic subgroup analysis.\r\n\r\nRESULTS\r\nOf 41 randomized patients (14F:27 M, AHIbaseline=49 [29, 62] events/hr; median [interquartile range]), 38 completed all interventions. Compared to sham, AHI was lowered with oxygen (estimate[CI]: -33[-46, -17]%), MAD (-54[-64, -41]%), and the combination (-68[-77, -57]%); the combination provided a greater reduction than MAD monotherapy (-14[-23, -4]%, p=0.009). The combination also improved AHI per 3% desaturation/arousal criteria (-73[-81, -62]% versus sham, -17[-25, -7]% versus MAD). The combination improved arousal index (-36[-43, -27]% versus sham) and VASSQ (+0.98[0.39, 1.58] versus sham), albeit not significantly beyond MAD alone. Effects were greatest in those with higher loop gain and collapsibility.\r\n\r\nCONCLUSION\r\nCombining a ventilatory control intervention (supplemental oxygen) with an upper airway intervention (MAD) is a promising approach to markedly attenuate OSA severity beyond that offered by each intervention alone.","PeriodicalId":12265,"journal":{"name":"European Respiratory Journal","volume":"10 1","pages":""},"PeriodicalIF":21.0000,"publicationDate":"2025-10-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Combined Supplemental Oxygen and Mandibular Advancement Device Therapy for Obstructive Sleep Apnea: A Randomized-Controlled Trial.\",\"authors\":\"Bradley A Edwards,Luke D J Thomson,Daniel Vena,Andrew Gikas,Reza Radmand,Nicole Calianese,Lauren B Hess,Jinny Collet,Dillon Gilbertson,Natalie V Lawrence,Shane A Landry,Simon A Joosten,Garun S Hamilton,Andrew Wellman,Scott A Sands\",\"doi\":\"10.1183/13993003.01320-2025\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"INTRODUCTION\\r\\nTreatment for obstructive sleep apnoea (OSA) is limited by intolerance to continuous positive airway pressure. While OSA manifests due to both increased pharyngeal collapsibility and ventilatory control instability, randomized trials targeting both components are lacking. We tested whether combining a ventilatory control intervention (supplemental oxygen) with an upper airway mechanical intervention (mandibular advancement devices, MAD) improves treatment efficacy.\\r\\n\\r\\nMETHODS\\r\\nIn a multicentre randomized crossover trial, 41 patients with moderate-to-severe OSA (apnoea-hypopnoea index [AHI] >20 events/hr, scored without desaturation criteria) underwent polysomnography with four single-night interventions: oxygen (4 L·min-1), MAD, combination therapy, and sham (air). Primary analysis compared percent change in AHI from baseline between combination therapy and MAD monotherapy. Secondary outcomes included arousal index and visual analog scale for sleep quality (VASSQ). Gold-standard baseline pathophysiological traits facilitated mechanistic subgroup analysis.\\r\\n\\r\\nRESULTS\\r\\nOf 41 randomized patients (14F:27 M, AHIbaseline=49 [29, 62] events/hr; median [interquartile range]), 38 completed all interventions. Compared to sham, AHI was lowered with oxygen (estimate[CI]: -33[-46, -17]%), MAD (-54[-64, -41]%), and the combination (-68[-77, -57]%); the combination provided a greater reduction than MAD monotherapy (-14[-23, -4]%, p=0.009). The combination also improved AHI per 3% desaturation/arousal criteria (-73[-81, -62]% versus sham, -17[-25, -7]% versus MAD). The combination improved arousal index (-36[-43, -27]% versus sham) and VASSQ (+0.98[0.39, 1.58] versus sham), albeit not significantly beyond MAD alone. Effects were greatest in those with higher loop gain and collapsibility.\\r\\n\\r\\nCONCLUSION\\r\\nCombining a ventilatory control intervention (supplemental oxygen) with an upper airway intervention (MAD) is a promising approach to markedly attenuate OSA severity beyond that offered by each intervention alone.\",\"PeriodicalId\":12265,\"journal\":{\"name\":\"European Respiratory Journal\",\"volume\":\"10 1\",\"pages\":\"\"},\"PeriodicalIF\":21.0000,\"publicationDate\":\"2025-10-02\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"European Respiratory Journal\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1183/13993003.01320-2025\",\"RegionNum\":1,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"RESPIRATORY SYSTEM\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"European Respiratory Journal","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1183/13993003.01320-2025","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"RESPIRATORY SYSTEM","Score":null,"Total":0}
Combined Supplemental Oxygen and Mandibular Advancement Device Therapy for Obstructive Sleep Apnea: A Randomized-Controlled Trial.
INTRODUCTION
Treatment for obstructive sleep apnoea (OSA) is limited by intolerance to continuous positive airway pressure. While OSA manifests due to both increased pharyngeal collapsibility and ventilatory control instability, randomized trials targeting both components are lacking. We tested whether combining a ventilatory control intervention (supplemental oxygen) with an upper airway mechanical intervention (mandibular advancement devices, MAD) improves treatment efficacy.
METHODS
In a multicentre randomized crossover trial, 41 patients with moderate-to-severe OSA (apnoea-hypopnoea index [AHI] >20 events/hr, scored without desaturation criteria) underwent polysomnography with four single-night interventions: oxygen (4 L·min-1), MAD, combination therapy, and sham (air). Primary analysis compared percent change in AHI from baseline between combination therapy and MAD monotherapy. Secondary outcomes included arousal index and visual analog scale for sleep quality (VASSQ). Gold-standard baseline pathophysiological traits facilitated mechanistic subgroup analysis.
RESULTS
Of 41 randomized patients (14F:27 M, AHIbaseline=49 [29, 62] events/hr; median [interquartile range]), 38 completed all interventions. Compared to sham, AHI was lowered with oxygen (estimate[CI]: -33[-46, -17]%), MAD (-54[-64, -41]%), and the combination (-68[-77, -57]%); the combination provided a greater reduction than MAD monotherapy (-14[-23, -4]%, p=0.009). The combination also improved AHI per 3% desaturation/arousal criteria (-73[-81, -62]% versus sham, -17[-25, -7]% versus MAD). The combination improved arousal index (-36[-43, -27]% versus sham) and VASSQ (+0.98[0.39, 1.58] versus sham), albeit not significantly beyond MAD alone. Effects were greatest in those with higher loop gain and collapsibility.
CONCLUSION
Combining a ventilatory control intervention (supplemental oxygen) with an upper airway intervention (MAD) is a promising approach to markedly attenuate OSA severity beyond that offered by each intervention alone.
期刊介绍:
The European Respiratory Journal (ERJ) is the flagship journal of the European Respiratory Society. It has a current impact factor of 24.9. The journal covers various aspects of adult and paediatric respiratory medicine, including cell biology, epidemiology, immunology, oncology, pathophysiology, imaging, occupational medicine, intensive care, sleep medicine, and thoracic surgery. In addition to original research material, the ERJ publishes editorial commentaries, reviews, short research letters, and correspondence to the editor. The articles are published continuously and collected into 12 monthly issues in two volumes per year.